Proteose peptone (PP) is a heat-stable and acidsoluble protein in milk whey. We reveal in this study the IgE production-suppressing activity of the PP fraction in bovine milk. The PP fraction suppressed IgE production by human myeloma cell line U266 cells by depressing the IgE mRNA expression. The suppressive activity of the PP fraction was facilitated by trypsin digestion. An oral administration of the PP fraction significantly decreased the levels of total and ovalbumin (OVA)-specific IgE in the serum collected from OVAsensitized mice. However, the serum levels of other Ig classes in OVA-sensitized mice were not affected by the intake of the PP fraction. The PP fraction suppressed the mRNA expression level of IgE in mice splenocytes collected from OVA-sensitized mice. Moreover, the B cell population in the spleen was decreased, while the T cell population was increased by administering the PP fraction. These results suggest that the PP fraction modified the B/T cell balance.
Bovine milk contains many kinds of functional substance, and some of them possess an immunostimulation effect. Casein, lactoferrin, and -lactoglobulin stimulate immunoglobulin production by lymphocytes and hybridoma cells in vitro. 1, 2) Bovine milk fermented by some types of fermentation bacteria also contains bioactive substances originated by fermentation. Hosoda et al. have reported that bovine milk cultured with lactic bacteria possessed anti-carcinogenic or anti-mutagenic activity. 3, 4) LeBlanc et al. have also reported that peptides from fermented milk stimulated humoral immune responses. 5) We have also revealed that a 19.0-kDa protein in fermented bovine milk stimulated immunoglobulin production in human hybridoma cells and human peripheral blood lymphocytes. 6) This protein was originally derived from proteose peptone component 3 (PP3) in bovine milk, and degraded by fermentation by 12 kinds of microorganisms.
PP is the heat-stable and acid-soluble fraction in milk whey. Although there are such PP proteins as components 3, 5, and 8, the biological functions of each PP component have not yet been fully elucidated. [7] [8] [9] [10] Homologous proteins have been characterized in the milk of such other species as the camel, 11) llama, 12) ewe, and caprine. 13, 14) However, PP3 has not been found in human milk. 15) A synthetic peptide of 23 residues corresponding to the carboxyterminal 113 to 135 region of PP3 has been investigated with regard to its antibacterial properties. 15) We have reported that PP3 had immunostimulating activity toward human hybridomas and peripheral blood lymphocytes. 6) Allergies have become a serious problem, especially for infants and children. 16) IgE is an immunoglobulin concerned with the allergic response. Binding of the allergen to IgE captured on mast cells and basophiles induces the release of such chemical mediators as histamine and leukotriene from these cells. IgE is an initial factor of the allergic reaction, so we have screened many factors suppressing the IgE production of immune cells to assist in the development of antiallergy products such as functional foods. This screening has revealed that a white sorghum (Sorghum bicolor (L.) Moench) bran extract suppressed IgE production by human myeloma U266 cells. 17) We also found that the PP fraction of bovine milk suppressed IgE production by U266 cells. This study is focused on the allergy suppression activity of the PP fraction of bovine milk in vitro and in vivo.
Materials and Methods
Reagents. The anti-human IgE antibody and biotin-conjugated antihuman IgE antibody were purchased from Biosource International (Camarillo, CA, USA). Goat anti-mouse IgG, biotinylated goat antimouse IgG, goat anti-mouse IgA, biotinylated goat anti-mouse IgA, and the horseradish peroxidase-streptavidin conjugate were from Invitrogen (Calsbad, CA, USA). BALB/c mice were from Japan SLC (Shizuoka, Japan), and the RPMI 1640 medium was purchased from Sigma (St. Louis, MO, USA).
Sample preparation. Fat-free bovine milk was heated at 90 C for 30 min. Following this heat treatment, the pH value was adjusted to 4.6 with 3 M HCl, precipitating the majority of caseins and denatured whey proteins. The precipitate was removed by centrifugation at 100;000 Â g for 30 min. The resulting supernatant was dialyzed against a 10 mM sodium phosphate buffer (NaPB at pH 7.4), sterilized by passing through a 0.22-mm filter (Millipore, Billerica, MA, USA), and used as the proteose peptone (PP) fraction.
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Assay of the IgE production-suppressing activity. The assay of the IgE production-suppressing effect of PP was performed in a 96-well culture plate. U266 cells were inoculated at 5:0 Â 10 4 cells/ml in the RPMI 1640 medium supplemented with 10 mg/ml of insulin, 20 mg/ml of transferrin, 20 mM ethanolamine, and 25 nM sodium selenite (ITES-RPMI 1640) supplemented with PP. After 24 h of cultivation, IgE produced in the culture medium was measured by an enzyme-linked immunosorbent assay (ELISA), using the anti-human IgE antibody. Briefly, 1.0 mg/ml of the goat anti-human IgE antibody in a 50 mM carbonate-bicarbonate buffer (pH 9.6) was added to a 96-well ELISA plate (Nunc, Roskilde, Denmark) at 100 ml/well, and the plate incubated for 2 h at 37 C. After washing three times with 0.05% Tween 20-PBS (T-PBS), each well was blocked with 1.0% bovine serum albumin (BSA)-PBS for 2 h at 37 C. After this blocking reaction, each well was washed three times with T-PBS and then treated with 50 ml of the culture supernatant for 1 h at 37 C. After washing three times with T-PBS, 100 ml of the biotinylated goat antihuman IgE antibody diluted 1,000 times with 1% BSA-PBS was added to each well, and the plate incubated for 1 h at 37 C. After washing again three times with T-PBS, 100 ml of the streptavidin-HRP conjugate (Invitrogen, Calsbad, CA, USA) diluted 4,000 times with 1% BSA-PBS was added to each well, and the plate incubated for 1 h more. The plate was again washed three times with T-PBS, 0.6 mg/ml of 2,2-azino-bis(ethylbenzothazoline-6-sulfonic acid diammonium salt) (ABTS) dissolved in a 0.03% H 2 O 2 -0.05 M citrate buffer (pH 4.0) was added to each well at 100 ml/well for enzyme reaction, and the absorbance at 415 nm was measured after adding 100 ml/well of 1.5% oxalic acid to terminate the enzyme reaction. The IgE concentration was quantitatively determined by a standard curve, using each human IgE standard solution.
IgE production-suppressing activity of the trypsin-treated PP fraction. The PP fraction (220 mg/ml of protein) was treated with 35, 150, and 375 mg/ml of trypsin for 15 min at 37 C, and trypsin was then inactivated by heating at 100 C for 2 min. U266 cells were cultured in the ITES-RPMI 1640 medium supplemented with inactivated trypsin as a control or with the trypsinized PP fraction at 6:0 Â 10 4 cells/ml. The amount of IgE in each culture medium was measured by ELISA after 24 h of cultivation.
Effect of PP on allergic model mice. Female 6-week-old BALB/c mice were kept under specific pathogen-free facilities. They were given free access to food and water, and the animal room was maintained under the following controlled conditions: temperature, 24 C; humidity, 55%; and 12-h light/12-h dark cycle. A specific allergic reaction against OVA was induced in the mice. After preliminary breeding for 1 week, the mice were orally given the dialyzed PP fraction or 10 mM NaPB as the control vehicle for 28 d. The protein concentration of the dialyzed PP fraction was 1,500 mg/ml, and each mouse (the average body weight was 20 g) was given 20 ml of the PP fraction/body/d. This means that the amount of the PP fraction administered was 1.5 mg/kg/d. In other words, a human (60 kg body weight) can take this mount of the PP fraction by drinking 400 ml of bovine milk every day. The mice received the first dose of OVA (100 mg/body) with an alum adjuvant (LSL, Japan) by an intraperitoneal (i.p.) injection on days 9 and 23 to elicit a specific IgE response.
18) Blood and splenocytes were collected 5 d after the second OVA challenge on day 23. The mice in the negative control (NC) group were orally administered same amount of the dialyzed PP fraction without immunization with OVA. The body weight was measured on alternate days for 28 d. All animal experiments were carried out in accordance with the protocol approved by Ehime University Animal Care and Use Committee and the applicable guidelines and regulations.
Preparation and culture of the spleen lymphocytes. Splenocytes were isolated from the spleen immediately after their excision for an ex vivo analysis. The splenocytes were strained through nylon mesh (40 nm pore size), and the collected cells were treated with a hemolysis buffer (155 mM NH 4 Cl, 15 mM NaHCO 3 , and 1 mM EDTA at pH 7.3). The splenocytes were obtained after washing twice with PBS and then inoculated in the RPMI 1640 medium supplemented with 5% FBS at 1 Â 10 6 cells/ml into a 96-well culture plate. After cultivating for 48 h, the culture supernatant was collected, and the Ig level determined by ELISA.
Measurement of immunoglobulin levels in sera. Sandwich ELISA was performed as previously described to measure the Ig levels in the sera and culture media.
19) The OVA-specific IgE level was determined by using a mouse OVA-specific IgE detection kit (Dainippon Sumitomo Pharma, Osaka, Japan).
Determination of the gene expression levels. Total RNA was isolated from splenocytes by using Sepasol-RNA I Super (Nacalai Tesque, Kyoto, Japan) according to the manufacturer's instructions. Total RNA (1 mg) was used as a template for a cDNA synthesis reaction performed with MMLV-reverse transcriptase (Promega, Madison, WI, USA) and an oligo-(dT) 20 primer (Toyobo, Osaka, Japan). Denaturation at 95 C for 1 min was followed by primer annealing at 60 C for 1 min, extension at 72 C for 1 min, and a final extension phase of 7 min. The cDNA was subjected to real-time PCR with the Step One Plus system (Applied Biosystems, Foster City, CA, USA). The amount of mRNA for human IgE was normalized to that for GAPDH, and mouse IgE and IL-4 was normalized to that foractin. The specific primer sequences for each gene were as follow. Flow cytometric analysis. Splenocytes prepared from OVA-immunized mice were washed with cold PBS. The cell surface markers on the splenocytes were stained on ice with FITC-conjugated anti-mouse B220 and PE-conjugated anti-mouse CD3 (Biolegend, San Diego, CA, USA) antibodies for 30 min. After washing with cold PBS, the cells were analyzed by using a FACSCalibur flow cytometer (BD Bioscience).
Statistical analysis. Each result is expressed as the mean AE SD. Student's t test was used to assess the statistical significance of the difference, p < 0:05 Ã , p < 0:01 ÃÃ , and p < 0:001 ÃÃÃ being considered statistically significant.
Results and Discussion
Effect of the PP fraction on IgE production by U266 cells
We had already screened the substances in food that suppress IgE production to ease allergy. We evaluated the effect of the PP fraction in bovine milk. As shown in Fig. 1 , the PP fraction reduced IgE production by U266 cells in a dose-dependent manner. The viability of the U266 cells was therefore not affected by the PP fraction at any dose (data not shown), and the PP fraction suppressed IgE productivity in the cells. Moreover, dialysis of the PP fraction showed that the IgE production-suppressing activity of this fraction was facilitated. This means that eliminating the low-molecular-weight substances (approx. <10 kDa) in the PP fraction facilitated the activity, and that the active substance was not of low molecular weight.
Fractionation of the active substance in the PP fraction by ultrafiltration
The active substance in the PP fraction did not pass through the dialysis membrane. To estimate the molecular weight of the active substance in this fraction, PP was fractionated by ultrafiltration. The filtrate passed through a 30-kDa ultrafiltration membrane did not suppress IgE production by U266 cells, and the active substance remained in the concentrate (Fig. 2) . This means that the molecular weight of the active substance or complex in the PP fraction was more than 30 kDa.
Effect of treating the PP fraction with trypsin on the IgE production-suppressing activity
To characterize the active substance in the PP fraction, the trypsin sensitivity of this substance was examined. Trypsin did not affect IgE production by U266 cells (data not shown). The data aree expressed as the relative suppression activity of the trypsinized PP fraction against the intact fraction (Fig. 3) . As indicated in Fig. 3 , the IgE production suppressing activity of the PP fraction was accelerated by trypsin digestion. The activity was enhanced approximately 2-fold by the trypsin treatment at 375 mg/ml compared with the intact PP fraction. The active substance in the PP fraction was modified and activated by the trypsin treatment in a dose-dependent manner. This result suggests that the substance in the PP fraction was a trypsin-sensitive protein, and partial modification of its molecular conformation resulted in activation of the substance.
IgE mRNA expression level in U266 cells treated with the PP fraction
The effect of the PP fraction on the expression level of mRNA for the IgE " chain in U266 cells was examined by quantitative real-time PCR. U266 cells were treated with the PP fraction for 24 h, and the " chain mRNA level was examined. As indicated in Fig. 4 , the " chain mRNA expression level in the U266 cells was obviously depressed by treating with 220 mg/ml of the PP fraction. It is presumed from this result that the decrease in IgE production was due to suppression of the expression level of " chain mRNA in the U266 cells. The dialyzed PP fraction (220 mg/ml) was treated with each concentration of trypsin at 37 C for 15 min. Trypsinization was terminated by heating at 100 C for 2 min. U266 cells were cultured in the ITES-RPMI 1640 medium supplemented with heat-treated trypsin as the control or with the trypsinized PP fraction at 6:0 Â 10 4 cells/ml. After 24 h of cultivation, the amount of IgE in each culture medium was measured by ELISA. Data are presented as the relative suppression activity against that of the intact PP fraction (n ¼ 3). Asterisks indicate that the data are significantly different from the control data.
Ã p < 0:05 and ÃÃ p < 0:01.
Effect of the PP fraction on the serum IgE level of allergic model mice
To examine the in vivo effect of an oral administration of the PP fraction on the specific allergy reaction, the mice were immunized with OVA. The serum was harvested on day 28, and the total and OVA-specific IgE levels were measured by ELISA. As indicated in Fig. 5A , the total IgE level in serum of the PP fraction-administrated group was significantly lower than that of the control vehicle group. In addition, the OVA-specific IgE level in the serum was also clearly decreased by PP administration (Fig. 5B) .
The levels of IgA, IgG, and IgM in the serum were measured. As summarized in Table 1 , the IgA, IgG, and IgM levels of the OVA-immunized mice were not affected by intake of the PP fraction. In addition, an ex vivo analysis revealed that IgA, IgG, and IgM production by splenocytes from the OVA-immunized mice was not activated by administering the PP fraction (data not shown). It is presumed from these findings that uptake of the PP fraction specifically decreased the serum IgE level in the allergic model mice, and did not affect the normal humoral immune response.
Effect of the PP fraction on IgE and IL-4 mRNA expression levels in splenocytes from the allergic model mice Administration of the PP fraction depressed the serum IgE level in the allergic model mice. We therefore evaluated the expression levels of IgE and IL-4 mRNA in splenocytes derived from the OVA-immunized mice. IL-4 activates the humoral immune response and induces B cells to produce IgE. As shown in Fig. 6 , the IgE " chain mRNA expression level in splenocytes was slightly suppressed by administering the PP fraction. It is presumed from this result that the decrease in IgE level in the serum was due to depression of the mRNA level in splenocytes. On the other hand, the IL-4 gene expression level in splenocytes was disposed to suppression by the PP intake, although the effect was not significant.
Effect of the PP fraction on the population of lymphocytes in the spleen
We next examined the effect of the PP fraction on the B/T cell proportion in the spleen. As shown in Fig. 7 , B cells in spleen were decreased by administering the PP fraction, and T cells were slightly increased. This result suggests that intake of the PP fraction relatively activated the cellular immune response compared with the humoral immune response in OVA-immunized mice. As indicated in Fig. 6 , the intake of PP was slightly disposed to suppression of the IL-4 expression level in splenocytes. It is presumed from these results that the intake of PP may have slightly suppressed the humoral immune response, and inactivated the allergy response.
We have presented in this study the anti-allergy effect of the PP fraction in bovine milk. IgE is a one of the major mediators of a type 1 immediate hypersensitivity reaction such as seasonal allergy, food allergy, asthma, and anaphylaxis. 20) The level of serum IgE in many individuals is roughly correlated with the severity of these allergic diseases. 21) We had previously investigated the biological function of the PP fraction in bovine milk, 6) so we examined in this study the effect of the PP fraction on IgE production by U266 cells. The results show that the PP fraction suppressed IgE production by depressing IgE mRNA expression in U266 cells. The activity of the PP fraction was accelerated by eliminating low-molecular-weight substances by dialysis. We are now purifying the active substance in the PP fraction. Although purification has not yet been completed, but we have estimated the molecular weight of the active substance in the PP fraction as 89 kDa by gel filtration (data not shown). Trypsin digestion activated the IgE production suppressing activity of the substance. It is presumed from these findings that the active substance was this 89-kDa protein, and that the activity of the degraded fragment would be stronger than that of the intact substance.
We orally administered the PP fraction to OVAchallenged allergy model mice. The PP fraction decreased the OVA-specific IgE level in the serum. The IgE expression level in splenocytes from OVAimmunized mice was down-regulated by the PP fraction, and IL-4 gene expression was slightly decreased. Moreover, intake of the PP fraction increased the T cell population and decreased the B cell population of splenocytes. It is presumed from these results that an intake of PP may inactivate the allergy response by suppressing the humoral immune response. Mice splenocytes were collected from the PP fraction-administered OVA-immunized mice. Total mRNA was prepared, and a quantitative real-time PCR assay was performed by using mRNAactin (internal control), IgE, and IL-4. Data are presented as the relative expression levels of mRNA for the IgE " chain and IL-4 in splenocytes from the PP fraction-administered allergy model mice against those from control vehicle allergy model mice (n ¼ 8 A cell population analysis of splenocytes from the PP fractionadministered OVA-challenged mice was performed. The cell surface markers on the splenocytes were stained on ice with FITCconjugated anti-mouse B220 and PE-conjugated anti-mouse CD3 antibodies for 30 min. After washing with cold PBS, the cells were analyzed by using a FACSCalibur flow cytometer.
